BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 5864163)

  • 1. Paniverine of a new type for the management of obliterative arterial diseases.
    Bugár-Mészáros K; Fonó J
    Ther Hung; 1965; 13(4):151-5. PubMed ID: 5864163
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the treatment of arterial circulatory disorders of the retina and optic nerve].
    Hager H
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1968; 68():382-9. PubMed ID: 5756803
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the use of an arterial wall extract (Liovasal) in the therapy of some retinal vascular diseases].
    Vitali G; Deledda MG
    Ann Ottalmol Clin Ocul; 1967 Dec; 93(12):1413-29. PubMed ID: 5605996
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical therapy in arterial disorders of the extremities: Vasodilator drugs.
    Myers KA
    Mod Treat; 1967 Mar; 4(2):370-85. PubMed ID: 5341885
    [No Abstract]   [Full Text] [Related]  

  • 5. [When are vasodilator agents effective in arterial occlusive diseases? Plethysmographic measurements in a double blind trial].
    Baitsch G; Schäfer M
    Med Welt; 1969 Aug; 35():1910-3. PubMed ID: 4897422
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of Tebonin in peripheral arterial circulatory disorders].
    Franke G; Maxis M
    Med Monatsschr; 1969 Mar; 23(3):128-30. PubMed ID: 5779072
    [No Abstract]   [Full Text] [Related]  

  • 7. [Conservative therapy of arterial occlusive diseases on a rational basis].
    Alexander K
    Dtsch Med J; 1972 May; 23(5):343-8. PubMed ID: 5036945
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of vasodilator drugs on walking, in chronic occlusion of the leg arteries.
    Schlüssel H
    Angiologica; 1966; 3(6):370-6. PubMed ID: 5958239
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasodilator agents].
    Bollinger A
    Schweiz Med Wochenschr; 1967 Sep; 97(37):1225-7. PubMed ID: 4874428
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medicinal prevention and therapy of arterial occlusive diseases of the extremities].
    Hild R
    Dtsch Med J; 1967 May; 18(10):306-12. PubMed ID: 5612094
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxpentifylline (Trental) in peripheral arterial disease.
    Drug Ther Bull; 1976 Jul; 14(15):59-60. PubMed ID: 964131
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
    Royer RJ
    Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343
    [No Abstract]   [Full Text] [Related]  

  • 13. [Critical observations on the pharmacotherapy of arterial circulation disorders of the extremities].
    Linke H
    Dtsch Gesundheitsw; 1965 Aug; 20(33):1505-16. PubMed ID: 5323383
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of heparin, aggregation inhibitors and vasoactive substances on chronic-obliterative vascular diseases].
    Wenzel E; Nienhaus KH; Bahre G; Holzhüter H; Angelkort B; Meyer-Erkelenz
    Med Welt; 1976 Jun; 27(25):1242-7. PubMed ID: 933811
    [No Abstract]   [Full Text] [Related]  

  • 15. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs].
    Bollinger A; Lüthy E
    Helv Med Acta Suppl; 1967 May; 47():128. PubMed ID: 5286297
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug therapy of arterial circulatory disorders with Lioftal].
    Greif S
    Munch Med Wochenschr; 1969 May; 111(18):1055-8. PubMed ID: 5819199
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasodilator drugs in the treatment of peripheral arterial diseases].
    Lorentsen E
    Tidsskr Nor Laegeforen; 1967 Jun; 87(11):1054-7. PubMed ID: 4860122
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl].
    Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC
    Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084
    [No Abstract]   [Full Text] [Related]  

  • 19. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with the vasodilator agent spasmocyclone].
    Priessnitz O
    Med Welt; 1966 Jun; 26():1433-6. PubMed ID: 5962718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.